The new diabetes company will be predominantly business-to-consumer, while Medtronic’s model was more business-to-business.

Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps ...

For the year, the company reported profit of $4.66 billion, or $3.61 per share. Revenue was reported as $33.54 billion.

Geoff Martha, Medtronic CEO, joins 'Money Movers' to discuss the company's spinoff plans, growth strategy and surgical ...

Medtronic is among the world’s largest makers of medical devices. - Jenn Ackerman for WSJ. Medical-device maker Medtronic ...

In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...

Medtronic (MDT) stock drops as the company's FY26 earnings guidance falls short of consensus, while its Q4 FY25 results beat ...

Medical device manufacturer Medtronic (MDT) plans to separate its diabetes business into a stand-alone company, ...

Medical device maker Medtronic plans to separate its diabetes business into a stand-alone company, the Wall Street Journal ...

Medtronic said Wednesday it plans to separate its diabetes business, which generates more than $2.8 billion in annual sales, ...

Medtronic's stock has shown a favorable one-day return following its earnings announcements in 53% of instances.

The noninferiority trial included 234 adults (five lost to follow-up) who were referred to seven sites across the U.S. for ...